Results 141 to 150 of about 45,546 (194)

Longer survival and favorable healthcare resource utilization of tagraxofusp versus venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm: results of a real-world analysis. [PDF]

Front Oncol
Stein AS, Guru Murthy GS, Vachhani P, Iyer S, Goldschmidt D, Gao Y, Katsetos J, Pelletier C, Kovacsovics T.   +8 more
europepmc   +1 more source

Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysis. [PDF]

BMC Cancer
Tan MW, Ling V, Tan JY, Chan WL, Thong E, Nagarajan C, Ong SY, Chen Y, Lim FL, Goh YT, Hwang WY, Ho AY, Koh LP, Tan LK, Lee J, Chan EH, de Mel S, Poon ML, Ng LC.   +18 more
europepmc   +1 more source

Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review. [PDF]

Hematol Transfus Cell Ther
Weihermann V, Maciel FVR, Velloso ED, Nardinelli L, Bendit I, Rocha V, Rego E, da Silva WF.   +7 more
europepmc   +1 more source

Efficacy of BEAM versus BeEAM conditioning regimens in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: a retrospective single-center study. [PDF]

Front Oncol
Akebaer S, Chen G, Xu J, Zhang K, Yang R, Han C, Hou J, Jiang M, Yuan H.   +8 more
europepmc   +1 more source

Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy. [PDF]

Ther Adv Hematol
Al-Mashdali AF, Abdelraof MO, Ibrahim M, Abdulgayoom M, Mohamed SF, Cherif H.   +5 more
europepmc   +1 more source

FLAG-Based versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Oncology
Abdulgayoom M, Aboukhalaf S, Osman M, H Soliman N, Rahmoon SM, Rabadi M, Fituri N, Al-Mashdali AF, Kaddoura R, F Mohamed S.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cytarabine

Journal of Pediatric Oncology Nursing, 1990
Cytarabine is effective in the treatment of leukemias and CNS disease when given SQ, IM, IV, or intrathecally. Research is continuing to investigate high-dose therapy with cytarabine.
D L, Betcher, N, Burnham
  +5 more sources